Work

Phase 1/2 Clinical Trial of Interferon α2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma

Year: 2007

Type: article

Study design: Clinical Trial

Source: Journal of Immunotherapy

DOI: 10.1097/cji.0b013e31805449a8

Authors: Stephen A. Boorjian, Matthew I. Milowsky, Jodi Kaplan, Martin Albert, Marta Vallee Cobham, Deirdre M. Coll, Nigel P. Mongan, Gary Shelton, Daniel Petrylak, Lorraine J. Gudas, David M. Nanus

Institutions: Cornell University, Weill Cornell Medicine, NewYork–Presbyterian Hospital

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G3249245898, Modulation of retinoic acid action in renal cancer, G7360908514

OpenAlex ID: W2063346644

FWCI: 2.603

Cites: 47

Cited by: 52

Related to: 10